This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ribes, J. A.
Right arrow Articles by Baker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ribes, J. A.
Right arrow Articles by Baker, D. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Fungal Infections

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, April 2000, p. 236-301, Vol. 13, No. 2
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Zygomycetes in Human Disease

Julie A. Ribes,1,2,* Carolyn L. Vanover-Sams,3 and Doris J. Baker3

Departments of Pathology and Laboratory Medicine and of Clinical Laboratory Sciences, University of Kentucky, Lexington, Kentucky 40536-00841; Veterans Affairs Medical Center, Lexington, Kentucky 40511-10932; and Department of Clinical Laboratory Sciences, University of Kentucky, Lexington, Kentucky 40536-00033

The Zygomycetes represent relatively uncommon isolates in the clinical laboratory, reflecting either environmental contaminants or, less commonly, a clinical disease called zygomycosis. There are two orders of Zygomycetes containing organisms that cause human disease, the Mucorales and the Entomophthorales. The majority of human illness is caused by the Mucorales. While disease is most commonly linked to Rhizopus spp., other organisms are also associated with human infection, including Mucor, Rhizomucor, Absidia, Apophysomyces, Saksenaea, Cunninghamella, Cokeromyces, and Syncephalastrum spp. Although Mortierella spp. do cause disease in animals, there is no longer sufficient evidence to suggest that they are true human pathogens. The spores from these molds are transmitted by inhalation, via a variety of percutaneous routes, or by ingestion of spores. Human zygomycosis caused by the Mucorales generally occurs in immunocompromised hosts as opportunistic infections. Host risk factors include diabetes mellitus, neutropenia, sustained immunosuppressive therapy, chronic prednisone use, iron chelation therapy, broad-spectrum antibiotic use, severe malnutrition, and primary breakdown in the integrity of the cutaneous barrier such as trauma, surgical wounds, needle sticks, or burns. Zygomycosis occurs only rarely in immunocompetent hosts. The disease manifestations reflect the mode of transmission, with rhinocerebral and pulmonary diseases being the most common manifestations. Cutaneous, gastrointestinal, and allergic diseases are also seen. The Mucorales are associated with angioinvasive disease, often leading to thrombosis, infarction of involved tissues, and tissue destruction mediated by a number of fungal proteases, lipases, and mycotoxins. If the diagnosis is not made early, dissemination often occurs. Therapy, if it is to be effective, must be started early and requires combinations of antifungal drugs, surgical intervention, and reversal of the underlying risk factors. The Entomophthorales are closely related to the Mucorales on the basis of sexual growth by production of zygospores and by the production of coenocytic hyphae. Despite these similarities, the Entomophthorales and Mucorales have dramatically different gross morphologies, asexual reproductive characteristics, and disease manifestations. In comparison to the floccose aerial mycelium of the Mucorales, the Entomophthorales produce a compact, glabrous mycelium. The asexually produced spores of the Entomophthorales may be passively released or actively expelled into the environment. Human disease with these organisms occurs predominantly in tropical regions, with transmission occurring by implantation of spores via minor trauma such as insect bites or by inhalation of spores into the sinuses. Conidiobolus typically infects mucocutaneous sites to produce sinusitis disease, while Basidiobolus infections occur as subcutaneous mycosis of the trunk and extremities. The Entomophthorales are true pathogens, infecting primarily immunocompetent hosts. They generally do not invade blood vessels and rarely disseminate. Occasional cases of disseminated and angioinvasive disease have recently been described, primarily in immunocompromised patients, suggesting a possible emerging role for this organism as an opportunist.

* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, MS-117, Medical Center, 800 Rose St., Lexington, KY 40536-0084. Phone: (606) 323-1368. Fax: (606) 323-5054. E-mail: jaribes{at}pop.uky.edu.

Clinical Microbiology Reviews, April 2000, p. 236-301, Vol. 13, No. 2
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Chakrabarti, A, Chatterjee, S S, Das, A, Panda, N, Shivaprakash, M R, Kaur, A, Varma, S C, Singhi, S, Bhansali, A, Sakhuja, V (2009). Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad. Med. J. 85: 573-581 [Abstract] [Full Text]  
  • Thrasher, J. D, Crawley, S. (2009). The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes. Toxicol Ind Health 25: 583-615 [Abstract]  
  • Cheng, V. C. C., Chan, J. F. W., Ngan, A. H. Y., To, K. K. W., Leung, S. Y., Tsoi, H. W., Yam, W. C., Tai, J. W. M., Wong, S. S. Y., Tse, H., Li, I. W. S., Lau, S. K. P., Woo, P. C. Y., Leung, A. Y. H., Lie, A. K. W., Liang, R. H. S., Que, T. L., Ho, P. L., Yuen, K. Y. (2009). Outbreak of Intestinal Infection Due to Rhizopus microsporus. J. Clin. Microbiol. 47: 2834-2843 [Abstract] [Full Text]  
  • Alvarez, E., Sutton, D. A., Cano, J., Fothergill, A. W., Stchigel, A., Rinaldi, M. G., Guarro, J. (2009). Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States. J. Clin. Microbiol. 47: 1650-1656 [Abstract] [Full Text]  
  • Lackner, G., Mobius, N., Scherlach, K., Partida-Martinez, L. P., Winkler, R., Schmitt, I., Hertweck, C. (2009). Global Distribution and Evolution of a Toxinogenic Burkholderia-Rhizopus Symbiosis. Appl. Environ. Microbiol. 75: 2982-2986 [Abstract] [Full Text]  
  • Thornton, C. R. (2009). Tracking the Emerging Human Pathogen Pseudallescheria boydii by Using Highly Specific Monoclonal Antibodies. CVI 16: 756-764 [Abstract] [Full Text]  
  • Alastruey-Izquierdo, A., Castelli, M. V., Cuesta, I., Monzon, A., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2009). Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers. Antimicrob. Agents Chemother. 53: 1686-1689 [Abstract] [Full Text]  
  • Khan, Z. U., Ahmad, S., Brazda, A., Chandy, R. (2009). Mucor circinelloides as a Cause of Invasive Maxillofacial Zygomycosis: an Emerging Dimorphic Pathogen with Reduced Susceptibility to Posaconazole. J. Clin. Microbiol. 47: 1244-1248 [Abstract] [Full Text]  
  • Madson, D. M., Loynachan, A. T., Kariyawasam, S., Opriessnig, T. (2009). Systemic Conidiobolus incongruus infection and hypertrophic osteopathy in a white-tailed deer (Odocoileus virginianus). jvdi 21: 167-170 [Abstract] [Full Text]  
  • Maida, C. M., Milici, M. E., Trovato, L., Oliveri, S., Amodio, E., Spreghini, E., Scalise, G., Barchiesi, F. (2008). Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi. J. Clin. Microbiol. 46: 4071-4074 [Abstract] [Full Text]  
  • Kasai, M., Harrington, S. M., Francesconi, A., Petraitis, V., Petraitiene, R., Beveridge, M. G., Knudsen, T., Milanovich, J., Cotton, M. P., Hughes, J., Schaufele, R. L., Sein, T., Bacher, J., Murray, P. R., Kontoyiannis, D. P., Walsh, T. J. (2008). Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis. J. Clin. Microbiol. 46: 3690-3702 [Abstract] [Full Text]  
  • Lechevalier, P., Hermoso, D. G., Carol, A., Bonacorsi, S., Ferkdadji, L., Fitoussi, F., Lortholary, O., Bourrillon, A., Faye, A., Dannaoui, E., Angoulvant, F. (2008). Molecular Diagnosis of Saksenaea vasiformis Cutaneous Infection after Scorpion Sting in an Immunocompetent Adolescent. J. Clin. Microbiol. 46: 3169-3172 [Abstract] [Full Text]  
  • Lionakis, M. S., Samonis, G., Kontoyiannis, D. P. (2008). Endocrine and Metabolic Manifestations of Invasive Fungal Infections and Systemic Antifungal Treatment. Mayo Clin Proc. 83: 1046-1060 [Abstract] [Full Text]  
  • Chamilos, G., Lewis, R. E., Hu, J., Xiao, L., Zal, T., Gilliet, M., Halder, G., Kontoyiannis, D. P. (2008). Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc. Natl. Acad. Sci. USA 105: 9367-9372 [Abstract] [Full Text]  
  • Perkhofer, S., Locher, M., Cuenca-Estrella, M., Ruchel, R., Wurzner, R., Dierich, M. P., Lass-Florl, C. (2008). Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro. Antimicrob. Agents Chemother. 52: 2636-2638 [Abstract] [Full Text]  
  • Hata, D. J., Buckwalter, S. P., Pritt, B. S., Roberts, G. D., Wengenack, N. L. (2008). Real-Time PCR Method for Detection of Zygomycetes. J. Clin. Microbiol. 46: 2353-2358 [Abstract] [Full Text]  
  • Thornton, C. R. (2008). Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis. CVI 15: 1095-1105 [Abstract] [Full Text]  
  • Chamilos, G., Lewis, R. E., Lamaris, G., Walsh, T. J., Kontoyiannis, D. P. (2008). Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-Like Receptor 2 Induction but Display Relative Resistance to Oxidative Damage. Antimicrob. Agents Chemother. 52: 722-724 [Abstract] [Full Text]  
  • Kontogiorgi, M., Floros, I., Koroneos, A., Vamvouka, C., Paniara, O., Roussos, C., Routsi, C. (2007). Fatal post-traumatic zygomycosis in an immunocompetent young patient. J Med Microbiol 56: 1243-1245 [Abstract] [Full Text]  
  • Almyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., Kusne, S. (2007). In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents. Antimicrob. Agents Chemother. 51: 2587-2590 [Abstract] [Full Text]  
  • Schwarz, P., Lortholary, O., Dromer, F., Dannaoui, E. (2007). Carbon Assimilation Profiles as a Tool for Identification of Zygomycetes. J. Clin. Microbiol. 45: 1433-1439 [Abstract] [Full Text]  
  • Stark, D., Milliken, S., Marriott, D., Harkness, J. (2007). Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course. J Med Microbiol 56: 699-701 [Abstract] [Full Text]  
  • Iwen, P. C., Sigler, L., Noel, R. K., Freifeld, A. G. (2007). Mucor circinelloides Was Identified by Molecular Methods as a Cause of Primary Cutaneous Zygomycosis. J. Clin. Microbiol. 45: 636-640 [Abstract] [Full Text]  
  • Lau, A., Chen, S., Sorrell, T., Carter, D., Malik, R., Martin, P., Halliday, C. (2007). Development and Clinical Application of a Panfungal PCR Assay To Detect and Identify Fungal DNA in Tissue Specimens. J. Clin. Microbiol. 45: 380-385 [Abstract] [Full Text]  
  • Cohen-Ludmann, C., Kerob, D., Feuilhade, M., Chaine, B., Guermazi, A., Janier, M., Levy, A., Verola, O., Morel, P., Lebbe, C., Lacroix, C. (2006). Zygomycosis of the Penis Due to Rhizopus oryzae Successfully Treated With Surgical Debridement and a Combination of High-Dose Liposomal and Topical Amphotericin B. Arch Dermatol 142: 1657-1658 [Full Text]  
  • White, M. M., James, T. Y., O'Donnell, K., Cafaro, M. J., Tanabe, Y., Sugiyama, J. (2006). Phylogeny of the Zygomycota based on nuclear ribosomal sequence data. Mycologia 98: 872-884 [Abstract] [Full Text]  
  • Paul, S., Marty, F. M., Colson, Y. L. (2006). Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.. Ann. Thorac. Surg. 82: 338-340 [Abstract] [Full Text]  
  • Enoch, D. A., Ludlam, H. A., Brown, N. M. (2006). Invasive fungal infections: a review of epidemiology and management options.. J Med Microbiol 55: 809-818 [Abstract] [Full Text]  
  • Machouart, M., Larche, J., Burton, K., Collomb, J., Maurer, P., Cintrat, A., Biava, M. F., Greciano, S., Kuijpers, A. F. A., Contet-Audonneau, N., de Hoog, G. S., Gerard, A., Fortier, B. (2006). Genetic Identification of the Main Opportunistic Mucorales by PCR-Restriction Fragment Length Polymorphism.. J. Clin. Microbiol. 44: 805-810 [Abstract] [Full Text]  
  • Schwarz, P., Bretagne, S., Gantier, J.-C., Garcia-Hermoso, D., Lortholary, O., Dromer, F., Dannaoui, E. (2006). Molecular Identification of Zygomycetes from Culture and Experimentally Infected Tissues. J. Clin. Microbiol. 44: 340-349 [Abstract] [Full Text]  
  • Chamilos, G., Lewis, R. E., Kontoyiannis, D. P. (2006). Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole. Antimicrob. Agents Chemother. 50: 96-103 [Abstract] [Full Text]  
  • Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., Schuster, M., Wingard, J. R., Gonzalez, C. E., Revankar, S. G., Corcoran, G., Kryscio, R. J., Hare, R. (2006). Posaconazole as Salvage Therapy for Zygomycosis. Antimicrob. Agents Chemother. 50: 126-133 [Abstract] [Full Text]  
  • Pimentel, J. D., Dreyer, G., Lum, G. D. (2006). Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol 55: 115-118 [Abstract] [Full Text]  
  • Brown, J. (2005). Zygomycosis: An emerging fungal infection. Am J Health Syst Pharm 62: 2593-2596 [Abstract] [Full Text]  
  • Iwen, P. C., Freifeld, A. G., Sigler, L., Tarantolo, S. R. (2005). Molecular Identification of Rhizomucor pusillus as a Cause of Sinus-Orbital Zygomycosis in a Patient with Acute Myelogenous Leukemia. J. Clin. Microbiol. 43: 5819-5821 [Abstract] [Full Text]  
  • Schlebusch, S., Looke, D. F. M. (2005). Intraabdominal Zygomycosis Caused by Syncephalastrum racemosum Infection Successfully Treated with Partial Surgical Debridement and High-Dose Amphotericin B Lipid Complex. J. Clin. Microbiol. 43: 5825-5827 [Abstract] [Full Text]  
  • Bialek, R, Konrad, F, Kern, J, Aepinus, C, Cecenas, L, Gonzalez, G M, Just-Nubling, G, Willinger, B, Presterl, E, Lass-Florl, C, Rickerts, V (2005). PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J. Clin. Pathol. 58: 1180-1184 [Abstract] [Full Text]  
  • Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., Hardalo, C. J. (2005). Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56: 745-755 [Abstract] [Full Text]  
  • Abdel-Naser, M. B., Yousef, N., El-Fakar, N. Z., Abdullatif, O. H., Wollina, U., Abdallah, M. A.-R. (2005). Invasive Zygomycosis With a Fatal Outcome. Arch Dermatol 141: 1211-1213 [Full Text]  
  • Spellberg, B., Edwards, J. Jr., Ibrahim, A. (2005). Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management. Clin. Microbiol. Rev. 18: 556-569 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J. (2005). Unusual Fungal and Pseudofungal Infections of Humans. J. Clin. Microbiol. 43: 1495-1504 [Full Text]  
  • Barron, M. A., Lay, M., Madinger, N. E. (2005). Surgery and Treatment with High-Dose Liposomal Amphotericin B for Eradication of Craniofacial Zygomycosis in a Patient with Hodgkin's Disease Who Had Undergone Allogeneic Hematopoietic Stem Cell Transplantation. J. Clin. Microbiol. 43: 2012-2014 [Abstract] [Full Text]  
  • Ibrahim, A. S., Bowman, J. C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J. E. Jr., Douglas, C. M. (2005). Caspofungin Inhibits Rhizopus oryzae 1,3-{beta}-D-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis. Antimicrob. Agents Chemother. 49: 721-727 [Abstract] [Full Text]  
  • Spellberg, B., Fu, Y., Edwards, J. E. Jr., Ibrahim, A. S. (2005). Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic Mice. Antimicrob. Agents Chemother. 49: 830-832 [Abstract] [Full Text]  
  • Ibrahim, A. S., Spellberg, B., Avanessian, V., Fu, Y., Edwards, J. E. Jr. (2005). Rhizopus oryzae Adheres to, Is Phagocytosed by, and Damages Endothelial Cells In Vitro. Infect. Immun. 73: 778-783 [Abstract] [Full Text]  
  • Lukacs, G., Papp, T., Nyilasi, I., Nagy, E., Vagvolgyi, C. (2004). Differentiation of Rhizomucor Species on the Basis of Their Different Sensitivities to Lovastatin. J. Clin. Microbiol. 42: 5400-5402 [Abstract] [Full Text]  
  • Aoki, K., Uchiyama, R., Yamauchi, S., Katayama, T., Itonori, S., Sugita, M., Hada, N., Yamada-Hada, J., Takeda, T., Kumagai, H., Yamamoto, K. (2004). Newly Discovered Neutral Glycosphingolipids in Aureobasidin A-resistant Zygomycetes: IDENTIFICATION OF A NOVEL FAMILY OF GALA-SERIES GLYCOLIPIDS WITH CORE Gal{alpha}1-6Gal{beta}1-6Gal{beta} SEQUENCES. J. Biol. Chem. 279: 32028-32034 [Abstract] [Full Text]  
  • Dannaoui, E., Meis, J. F. G. M., Loebenberg, D., Verweij, P. E. (2003). Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis. Antimicrob. Agents Chemother. 47: 3647-3650 [Abstract] [Full Text]  
  • Thomas, P. A. (2003). Current Perspectives on Ophthalmic Mycoses. Clin. Microbiol. Rev. 16: 730-797 [Abstract] [Full Text]  
  • Ibrahim, A. S., Avanessian, V., Spellberg, B., Edwards, J. E. Jr. (2003). Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae. Antimicrob. Agents Chemother. 47: 3343-3344 [Abstract] [Full Text]  
  • Vitale, R. G., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E. (2003). Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media. J Antimicrob Chemother 52: 65-70 [Abstract] [Full Text]  
  • Chakrabarti, A., Ghosh, A., Prasad, G. S., David, J. K., Gupta, S., Das, A., Sakhuja, V., Panda, N. K., Singh, S. K., Das, S., Chakrabarti, T. (2003). Apophysomyces elegans: an Emerging Zygomycete in India. J. Clin. Microbiol. 41: 783-788 [Abstract] [Full Text]  
  • Dannaoui, E., Rijs, A. J. M. M., Verweij, P. E. (2003). Invasive Infections Due to Apophysomyces elegans. Mayo Clin Proc. 78: 252-253  
  • Levy, J. M., Levin, R. S., Clancy, J. T. (2003). Lower-Extremity Wounds Inflicted by Rats. J. Am. Podiatr. Med. Assoc. 93: 58-61 [Full Text]  
  • Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]  
  • Dannaoui, E., Afeltra, J., Meis, J. F. G. M., Verweij, P. E. (2002). In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents. Antimicrob. Agents Chemother. 46: 2708-2711 [Abstract] [Full Text]  
  • Sun, Q. N., Najvar, L. K., Bocanegra, R., Loebenberg, D., Graybill, J. R. (2002). In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model. Antimicrob. Agents Chemother. 46: 2310-2312 [Abstract] [Full Text]  
  • Blair, J. E., Fredrikson, L. J., Pockaj, B. A., Lucaire, C. S. (2002). Locally Invasive Cutaneous Apophysomyces elegans Infection Acquired From Snapdragon Patch Test. Mayo Clin Proc. 77: 717-720 [Abstract]  
  • Dannaoui, E., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E. (2002). Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis. Antimicrob. Agents Chemother. 46: 1953-1959 [Abstract] [Full Text]  
  • Dannaoui, E., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E., the Eurofung Network, (2002). In vitro susceptibilities of Zygomycota to polyenes. J Antimicrob Chemother 49: 741-744 [Abstract] [Full Text]  
  • Sun, Q. N., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G., Graybill, J. R. (2002). In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes. Antimicrob. Agents Chemother. 46: 1581-1582 [Abstract] [Full Text]  
  • Cloughley, R., Kelehan, J., Corbett-Feeney, G., Murray, M., Callaghan, J., Regan, P., Cormican, M. (2002). Soft Tissue Infection with Absidia corymbifera in a Patient with Idiopathic Aplastic Anemia. J. Clin. Microbiol. 40: 725-727 [Abstract] [Full Text]  
  • Gomez-Lopez, A., Cuenca-Estrella, M., Monzon, A., Rodriguez-Tudela, J. L. (2001). In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother 48: 919-921 [Abstract] [Full Text]  
  • Khan, Z. U., Khoursheed, M., Makar, R., Al-Waheeb, S., Al-Bader, I., Al-Muzaini, A., Chandy, R., Mustafa, A. S. (2001). Basidiobolus ranarum as an Etiologic Agent of Gastrointestinal Zygomycosis. J. Clin. Microbiol. 39: 2360-2363 [Abstract] [Full Text]  
  • Davel, G., Featherston, P., Fernández, A., Abrantes, R., Canteros, C., Rodero, L., Sztern, C., Perrotta, D. (2001). Maxillary Sinusitis Caused by Actinomucor elegans. J. Clin. Microbiol. 39: 740-742 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»